ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07024
0,00%
Bitcoin
66.417,34
-0,33%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Melinta Therapeutics Inc (MLNT)

  7. Melinta Therapeutics Inc (MLNT) News

MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MLNT
DatumZeitQuelleÜberschriftSymbolFirma
24/06/202022h02GlobeNewswire Inc.Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of TetraphaseNASDAQ:MLNTMelinta Therapeutics Inc
09/06/202022h02GlobeNewswire Inc.Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase PharmaceuticalsNASDAQ:MLNTMelinta Therapeutics Inc
04/03/202022h03GlobeNewswire Inc.Melinta Therapeutics Confirms Deerfield as Successful Bidder for CompanyNASDAQ:MLNTMelinta Therapeutics Inc
13/02/202022h02GlobeNewswire Inc.Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:MLNTMelinta Therapeutics Inc
05/02/202017h15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MLNTMelinta Therapeutics Inc
08/01/202022h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201915h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201915h02GlobeNewswire Inc.Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityNASDAQ:MLNTMelinta Therapeutics Inc
12/11/201923h07GlobeNewswire Inc.Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019NASDAQ:MLNTMelinta Therapeutics Inc
12/11/201923h00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
06/11/201923h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201918h54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201918h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201922h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201922h02GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...NASDAQ:MLNTMelinta Therapeutics Inc
01/10/201916h07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:MLNTMelinta Therapeutics Inc
13/09/201921h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201922h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201922h05GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorNASDAQ:MLNTMelinta Therapeutics Inc
13/08/201912h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913h41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913h38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913h31GlobeNewswire Inc.Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanNASDAQ:MLNTMelinta Therapeutics Inc
09/08/201913h30GlobeNewswire Inc.Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:MLNTMelinta Therapeutics Inc
06/08/201923h04GlobeNewswire Inc.Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingNASDAQ:MLNTMelinta Therapeutics Inc
16/07/201922h51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
16/07/201913h30GlobeNewswire Inc.Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
10/07/201921h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNTMelinta Therapeutics Inc
02/07/201923h23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
01/07/201923h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLNT

Kürzlich von Ihnen besucht

TG
DBK
Deutsche Bank
TG
NOV
Novo Nordisk
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
TG
CBK
Commerzbank
CCOM
US500
US 500
NYSE
JPM
JP Morgan Chase
FX
EURUSD
Euro vs US Dollar
TG
432
Arbor Metals
CCOM
SILVER
SILVER
TG
RHM
Rheinmetall
DBI
TDXP
Tec DAX
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
TG
DTE
Deutsche Telekom
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten